http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5985932-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 1997-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397d6604e09e6b353b0db023d2facc0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70ec71b0d43fc4c412f7520d9ae746b9 |
| publicationDate | 1999-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5985932-A |
| titleOfInvention | Inhibition of autoimmune diseases |
| abstract | The present invention provides novel methods of inhibition of autoimmune diseases comprising administering to a mammal in need of treatment an effective amount of a compound of formula I wherein R1 and R2 may be the same or different provided that, when R1 and R2 are the same, each is a methyl or ethyl group, and, when R1 and R2 are different, one of them is a methyl or ethyl group and the other is hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof. |
| priorityDate | 1996-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 242.